Nordea Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,475
Closed -$423K 951
2020
Q3
$423K Sell
1,475
-1,475
-50% -$347K ﹤0.01% 841
2020
Q2
$546K Buy
+2,950
New +$480K ﹤0.01% 870
2020
Q1
Sell
-1,305
Closed -$219K 968
2019
Q4
$219K Buy
+1,305
New +$217K ﹤0.01% 942
2019
Q3
Sell
-1,068
Closed -$132K 984
2019
Q2
$132K Sell
1,068
-99,122
-99% -$12.6M ﹤0.01% 971
2019
Q1
$13.2M Sell
100,190
-500
-0.5% -$67.5K 0.03% 343
2018
Q4
$14.1M Buy
100,690
+26,568
+36% +$3.52M 0.03% 320
2018
Q3
$12.8M Buy
+74,122
New +$12.5M 0.03% 348
2018
Q2
Sell
-64,240
Closed -$10.8M 1086
2018
Q1
$10.8M Buy
+64,240
New +$8.7M 0.03% 297

Other funds holding ONC

Nordea Investment Management's ONC Position: Q4 2020 in Review

Nordea Investment Management sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 1,475 shares — an estimated $423K sold.

Nordea Investment Management first reported a position in ONC in Q1 2018 and held it in 8 quarters. The position peaked at $14.1M in Q4 2018. 248 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

  • Nordea Investment Management reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
  • Nordea Investment Management sold 1,475 BeOne Medicines Ltd shares in Q4 2020, an estimated $423K.
  • Nordea Investment Management first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 8 quarters.
  • Nordea Investment Management's BeOne Medicines Ltd position peaked at $14.1M in Q4 2018.
  • 248 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Nordea Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.